DOI: 10.1136/bmj-2024-080409 Meng-Ting Wang et al, Environmentally friendly inhaler regimens for COPD, BMJ (2024). DOI: 10.1136/bmj.q2825 ...
Metered-dose inhaler budesonide-glycopyrrolate-formoterol (Breztri Aerosphere) was associated with a higher risk of a first moderate or severe COPD exacerbation (HR 1.09, 95% CI 1.04-1.14 ...
AZ’s single inhaler, PT010 ... for medicines that could reduce likelihood of expensive emergency hospital visits due to COPD. Further details of the KRONOS trial will be announced at an upcoming ...
Amarillo Globe-News on MSN16h
What are Zephyr Valves? Groundbreaking COPD treatment brings hope to Panhandle patientsAfter waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
News Medical on MSN5d
The impact of fall-risk medications on injuries in COPD patientsPeople with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...
Hosted on MSN1mon
Are dry powder inhalers the key to sustainable respiratory care?Additionally, a pMDI with a spacer is preferred to provide a sufficient dose in an emergency situation ... GSK, leading the COPD market with its Trelegy Ellipta inhaler, is planning pivotal ...
6don MSN
People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing drugs, according to a recent study. The research is published in Chronic ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers ... disease (COPD). Sales of Breztri ...
Addressing a workshop titled "Phasing out CFC in Metered Dose Inhalers", Mr Singh said, "Environment-friendly asthma and COPD (Chronic Obstructive Pulmonary Diseases) inhalers are being introduced ...
“We are proud to continue advancing our asthma and COPD inhaled drug program, achieving key clinical development milestones on schedule,” said Xian-Ming Zeng, Ph.D., CEO of Transpire Bio.
HealthDay on MSN10d
Study Compares Single-Inhaler Triple Therapies for Treatment of COPDFor patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback